The global market for Cardiac Defibrillators is estimated at US$13.4 Billion in 2023 and is projected to reach US$22.9 Billion by 2030, growing at a CAGR of 7.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The integration of Artificial Intelligence (AI) and the Internet of Things (IoT) into defibrillators enables predictive maintenance, real-time monitoring, and connectivity. Artificial Intelligence (AI) significantly impacts how defibrillators work, making them more efficient through machine learning algorithms that enhance life-saving treatments. Wearable defibrillators have become popular as non-invasive, temporary solutions for patients awaiting implantable devices. Subcutaneous implantable defibrillators (S-ICD) are gaining traction because of their less invasive nature, which reduces infection risk. Additionally, smart monitoring enables continuous, real-time patient monitoring and data sharing with healthcare providers.
The integration of Artificial Intelligence (AI) and the Internet of Things (IoT) into defibrillators enables predictive maintenance, real-time monitoring, and connectivity. Artificial Intelligence (AI) significantly impacts how defibrillators work, making them more efficient through machine learning algorithms that enhance life-saving treatments. Wearable defibrillators have become popular as non-invasive, temporary solutions for patients awaiting implantable devices. Subcutaneous implantable defibrillators (S-ICD) are gaining traction because of their less invasive nature, which reduces infection risk. Additionally, smart monitoring enables continuous, real-time patient monitoring and data sharing with healthcare providers.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Implantable / Internal Cardiac Defibrillator segment, which is expected to reach US$12.3 Billion by 2030 with a CAGR of a 6.1%. The External Cardiac Defibrillator segment is also set to grow at 10.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $3.6 Billion in 2023, and China, forecasted to grow at an impressive 7.5% CAGR to reach $3.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Cardiac Defibrillators Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Cardiac Defibrillators Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Cardiac Defibrillators Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Laboratories, Biotronik GmbH & Co. KG, Boston Scientific Corporation, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 48 Featured):
- Abbott Laboratories
- Biotronik GmbH & Co. KG
- Boston Scientific Corporation
- Cardiac Science Corporation
- GE Healthcare Ltd.
- Medtronic, Inc.
- Philips Healthcare
- Physio-Control Inc.
- St. Jude Medical Inc.
- Zoll Medical Corporation
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
Companies Mentioned
- Abbott Laboratories
- Biotronik GmbH & Co. KG
- Boston Scientific Corporation
- Cardiac Science Corporation
- GE Healthcare Ltd.
- Medtronic, Inc.
- Philips Healthcare
- Physio-Control Inc.
- St. Jude Medical Inc.
- Zoll Medical Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 276 |
Published | November 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 13.4 Billion |
Forecasted Market Value ( USD | $ 22.9 Billion |
Compound Annual Growth Rate | 7.9% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |